Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions.
TRPM4 mRNA expression levels in peripheral blood mononuclear cells from multiple sclerosis patients.
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome.
Pain: Comorbidity of neuropathic pain and migraine in patients with multiple sclerosis.
Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells.
The gateway theory: bridging neural and immune interactions in the CNS.
The gateway theory: How regional neural activation creates a gateway for immune cells via an inflammation amplifier.
Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.
Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination.
DRUG DELIVERY TO CNS: CHALLENGES AND OPPORTUNITIES WITH EMPHASIS ON BIOMATERIALS BASED DRUG DELIVERY STRATEGIES.
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.
The treatment of neuromyelitis optica.
Systematic framework to evaluate the status of physical activity research for persons with multiple sclerosis.
BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis.
I-BET151 selectively regulates IL-6 production.
Seronegative Neuromyelitis Optica Spectrum - The challenges on disease definition and pathogenesis.
Autophagy and neurodegeneration.
Microglia: Multitasking Specialists of the Brain.
Comparing voice self-assessment with auditory perceptual analysis in patients with multiple sclerosis.
DGPPN guideline on anxiety disorders and cognitive dysfunction in the elderly or patients with multiple sclerosis.
Prevalence and risk factors of low bone mineral density in patients with multiple sclerosis.
Clinical response to interferon beta and glatiramer acetate in multiple sclerosis patients: a Brazilian cohort.
Clinical features of Chinese patients with multiple sclerosis with aquaporin-4 antibodies in cerebrospinal fluid but not serum.
Seropositive Neuromyelitis Optica: A Pediatric Case Report and 6-Year Follow-Up.
Local dynamic stability as a responsive index for the evaluation of rehabilitation effect on fall risk in patients with multiple sclerosis: a longitudinal study.
Pages
« first
‹ previous
…
508
509
510
511
512
513
514
515
516
…
next ›
last »